The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biopharmaceutical Fermentation Systems-Global Market Insights and Sales Trends 2024
Synopsis
Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.
The global Biopharmaceutical Fermentation Systems market size is expected to reach US$ 13130 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Biopharmaceutical Fermentation Systems in various end use industries. The expanding demands from the Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations and Academic Research Institutes, are propelling Biopharmaceutical Fermentation Systems market. Fermenters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioprocess Analyzers segment is estimated at % CAGR for the next seven-year period.
In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharmaceutical Fermentation Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharmaceutical Fermentation Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharmaceutical Fermentation Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharmaceutical Fermentation Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharmaceutical Fermentation Systems covered in this report include GE Healthcare, Thermo Fisher Scientific, Danaher, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals and Lonza, etc.
The global Biopharmaceutical Fermentation Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Thermo Fisher Scientific
Danaher
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton
Dickinson and Company
GEA
Global Biopharmaceutical Fermentation Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharmaceutical Fermentation Systems market, Segment by Type:
Fermenters
Bioprocess Analyzers
Process Monitoring Devices
Culture & Media Preparation
Culture Media, Buffers & Inducers
Others
Global Biopharmaceutical Fermentation Systems market, by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Academic Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharmaceutical Fermentation Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.
The global Biopharmaceutical Fermentation Systems market size is expected to reach US$ 13130 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Biopharmaceutical Fermentation Systems in various end use industries. The expanding demands from the Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations and Academic Research Institutes, are propelling Biopharmaceutical Fermentation Systems market. Fermenters, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioprocess Analyzers segment is estimated at % CAGR for the next seven-year period.
In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biopharmaceutical Fermentation Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biopharmaceutical Fermentation Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biopharmaceutical Fermentation Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biopharmaceutical Fermentation Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biopharmaceutical Fermentation Systems covered in this report include GE Healthcare, Thermo Fisher Scientific, Danaher, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals and Lonza, etc.
The global Biopharmaceutical Fermentation Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Thermo Fisher Scientific
Danaher
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton
Dickinson and Company
GEA
Global Biopharmaceutical Fermentation Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biopharmaceutical Fermentation Systems market, Segment by Type:
Fermenters
Bioprocess Analyzers
Process Monitoring Devices
Culture & Media Preparation
Culture Media, Buffers & Inducers
Others
Global Biopharmaceutical Fermentation Systems market, by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Academic Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biopharmaceutical Fermentation Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biopharmaceutical Fermentation Systems
1.1 Biopharmaceutical Fermentation Systems Market Overview
1.1.1 Biopharmaceutical Fermentation Systems Product Scope
1.1.2 Biopharmaceutical Fermentation Systems Market Status and Outlook
1.2 Global Biopharmaceutical Fermentation Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biopharmaceutical Fermentation Systems Market Size by Region (2018-2029)
1.4 Global Biopharmaceutical Fermentation Systems Historic Market Size by Region (2018-2023)
1.5 Global Biopharmaceutical Fermentation Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biopharmaceutical Fermentation Systems Market Size (2018-2029)
1.6.1 North America Biopharmaceutical Fermentation Systems Market Size (2018-2029)
1.6.2 Europe Biopharmaceutical Fermentation Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size (2018-2029)
1.6.4 Latin America Biopharmaceutical Fermentation Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (2018-2029)
2 Biopharmaceutical Fermentation Systems Market by Type
2.1 Introduction
2.1.1 Fermenters
2.1.2 Bioprocess Analyzers
2.1.3 Process Monitoring Devices
2.1.4 Culture & Media Preparation
2.1.5 Culture Media, Buffers & Inducers
2.1.6 Others
2.2 Global Biopharmaceutical Fermentation Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biopharmaceutical Fermentation Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biopharmaceutical Fermentation Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biopharmaceutical Fermentation Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biopharmaceutical Fermentation Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biopharmaceutical Fermentation Systems Revenue Breakdown by Type (2018-2029)
3 Biopharmaceutical Fermentation Systems Market Overview by Application
3.1 Introduction
3.1.1 Biopharmaceutical Companies
3.1.2 Contract Manufacturing Organizations
3.1.3 Contract Research Organizations
3.1.4 Academic Research Institutes
3.1.5 Others
3.2 Global Biopharmaceutical Fermentation Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biopharmaceutical Fermentation Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biopharmaceutical Fermentation Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biopharmaceutical Fermentation Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biopharmaceutical Fermentation Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biopharmaceutical Fermentation Systems Revenue Breakdown by Application (2018-2029)
4 Biopharmaceutical Fermentation Systems Competition Analysis by Players
4.1 Global Biopharmaceutical Fermentation Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharmaceutical Fermentation Systems as of 2022)
4.3 Date of Key Players Enter into Biopharmaceutical Fermentation Systems Market
4.4 Global Top Players Biopharmaceutical Fermentation Systems Headquarters and Area Served
4.5 Key Players Biopharmaceutical Fermentation Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharmaceutical Fermentation Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.1.4 GE Healthcare Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.3.4 Danaher Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Sartorius StedimBiotech Recent Developments
5.4 Sartorius StedimBiotech
5.4.1 Sartorius StedimBiotech Profile
5.4.2 Sartorius StedimBiotech Main Business
5.4.3 Sartorius StedimBiotech Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.4.4 Sartorius StedimBiotech Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Sartorius StedimBiotech Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.5.4 Merck Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Eppendorf
5.6.1 Eppendorf Profile
5.6.2 Eppendorf Main Business
5.6.3 Eppendorf Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.6.4 Eppendorf Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.6.5 Eppendorf Recent Developments
5.7 Roche
5.7.1 Roche Profile
5.7.2 Roche Main Business
5.7.3 Roche Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.7.4 Roche Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Recent Developments
5.8 Nova Biomedicals
5.8.1 Nova Biomedicals Profile
5.8.2 Nova Biomedicals Main Business
5.8.3 Nova Biomedicals Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.8.4 Nova Biomedicals Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.8.5 Nova Biomedicals Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.9.4 Lonza Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 Becton
5.10.1 Becton Profile
5.10.2 Becton Main Business
5.10.3 Becton Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.10.4 Becton Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.10.5 Becton Recent Developments
5.11 Dickinson and Company
5.11.1 Dickinson and Company Profile
5.11.2 Dickinson and Company Main Business
5.11.3 Dickinson and Company Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.11.4 Dickinson and Company Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.11.5 Dickinson and Company Recent Developments
5.12 GEA
5.12.1 GEA Profile
5.12.2 GEA Main Business
5.12.3 GEA Biopharmaceutical Fermentation Systems Products, Services and Solutions
5.12.4 GEA Biopharmaceutical Fermentation Systems Revenue (US$ Million) & (2018-2023)
5.12.5 GEA Recent Developments
6 North America
6.1 North America Biopharmaceutical Fermentation Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biopharmaceutical Fermentation Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Fermentation Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biopharmaceutical Fermentation Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Fermentation Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biopharmaceutical Fermentation Systems Market Dynamics
11.1 Biopharmaceutical Fermentation Systems Industry Trends
11.2 Biopharmaceutical Fermentation Systems Market Drivers
11.3 Biopharmaceutical Fermentation Systems Market Challenges
11.4 Biopharmaceutical Fermentation Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
